Insurance Industry and Insurtech Report — 2026-07-11
Domestic insurers are revolutionizing customer management through AI-driven hyper-personalized healthcare, while global counterparts are strengthening competitiveness through AI innovation and strategic healthcare partnerships. Meanwhile, the medical device sector in the US and the Asia-Pacific region is accelerating global market expansion through digital transformation and innovative technology.
Insurance Industry and Insurtech Report — 2026-07-11
Domestic Insurance Industry Trends
Expanding Customer Management via Hyper-personalized AI Healthcare
Domestic insurance companies are expanding AI-driven, hyper-personalized healthcare services across their insurance products and customer management systems. The industry is pursuing strategies to boost customer loyalty by providing personalized healthcare, ranging from real-time dietary suggestions like "reduce your carbohydrate intake today" to health-status-specific management. This is seen as a new business model that goes beyond simple insurance products to intervene deeply in the daily health management of customers.
Push for Digital Healthcare Regulatory Reform
Despite the rapid expansion of the digital healthcare market, which integrates domestic AI and data technology, critics argue that the supporting legal framework remains in its infancy. Unlike in the US, domestic companies are facing instances where patient-data-driven clinical support services are blocked by regulations, forcing them to abandon projects or pivot to entirely different sectors. Consequently, regulatory reform through legislative restarts is considered an urgent necessity.
Global Insurtech and Healthcare Achievements
Philippine Insurer Gains International Recognition for AI Telemedicine Platform
Philippine HMO insurer iCare won two major awards at the 2026 Insurance Asia Awards. They received "AI Initiative of the Year - Philippines" for their Telemed7 platform and "Strategic Partnership of the Year - Philippines" for their Super Preferred Clinics (SPC) program. This serves as a case study of an insurer gaining international recognition through AI-based telemedicine solutions and strategic healthcare partnerships, proving the viability of an integrated insurance-healthcare model in the Asia-Pacific region.
Swiss Re Highlights AI Investment in 2026 Insurance Outlook
In its 2026 Global Insurance Industry Outlook report, the Swiss reinsurer Swiss Re predicted that geopolitical tensions and supply chain disruptions would slow premium growth, while emphasizing AI investment and technological innovation as strategies to strengthen insurers' competitiveness. This highlights the strategic direction of the global insurance industry to maintain profitability through AI-based innovation even in an uncertain macroeconomic environment.
Asia-Pacific Emerges as a Hub for Global Medical Device Innovation
According to a recent report by Bain & Company, the medical device sector in the Asia-Pacific (APAC) region is undergoing radical structural change, shifting from its past role of absorbing Western medical devices to becoming a major exporter of global medical device innovation. This is a significant trend suggesting that the demand for healthcare technology partnerships in the insurance industry will rise across the Asian region.
Market Insights and Analysis
The Rise of a "Data-Centric" Paradigm Combining Insurance and Healthcare
Two important changes can be observed in recent trends across the domestic and international insurance industries.
First, the realization of data-driven hyper-personalization models. The domestic insurance industry's use of "AI-based carbohydrate intake suggestions" signifies a shift away from past incentives like "insurance premium discounts" toward a new strategy of intervening in real-time health management. Similar to the success of iCare's Telemed7 platform in the Philippines, it is emphasized that personalized preventive medical services become possible when data integration between insurers and healthcare institutions is enabled.
Second, the need to bridge the gap between regulation and technology. Despite the rapid growth of the digital healthcare market domestically, the lagging regulatory framework remains a major obstacle to insurance-healthcare integration. Conversely, in the Philippines and other parts of Asia, the regulatory environment is more flexible, leading to active development of AI-based insurance products. The emphasis on AI investment by Swiss Re and the global reinsurance industry suggests that if regulatory improvements are made, the pace of technological innovation among domestic insurers could accelerate.
Bain & Company's analysis that the Asia-Pacific region is emerging as a global hub for medical device innovation suggests that healthcare technology partnerships for domestic insurers will likely become more active, which is evaluated as a move that will strengthen the technical foundation for hyper-personalized healthcare services.
[Sources]
- Insurer hyper-personalized healthcare services:
- Digital healthcare regulatory issues:
- iCare Insurance Asia Awards:
- Swiss Re 2026 Outlook:
- Bain & Company APAC medical device innovation: https://www.businesstoday.com.my/2026/07/07/asia-pacific-becoming-primary-exporter-of-global-healthcare-innovation-bain-report/
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
